The cabazitaxel trial finished by the 17th of April. Six months ago. There were a total of 76 patients, treated over a number of years. To wait this long, and longer, for the top line results to be announced is…dreadful.
What are they doing? Running down the cash reserves? With the termination of AZD0466 and shelving DEP Gemcitabine there is a growing gap between the secretive pre clinical work and the DEP phase 2 completion. And how long did it take to get those three drugs through phase 1 and 2?
To quote the London Underground “MIND THE GAP!”
Expectats for October, page-40
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |